Abiomed: 100 Centers Penetrated, Encouraging on Both Commercial and Trial Enrollment Fronts

ABMD: 100 Centers Penetrated, Encouraging on Both Commercial and Trial Enrollment Fronts

Posted on September 30th, 2008

Abiomed announces that its Impella 2.5 VAD is now commercially available in 100 hospitals in the United States.

2008 09-30 Abiomed Impella LCM BUY

About Anthem Equity Group

Anthem is an open-integrated company where our investors, lenders, vendors and team members are part of a seamless organization, committed to working together to maximize our returns in a climate of opportunity and uncertainty. Today’s modern communication tools form the platform for this strategy.